-
Signature
-
/s/ Paul Breaux, by Power of Attorney for Thomas Taira
-
Stock symbol
-
CVNA
-
Transactions as of
-
May 8, 2025
-
Transactions value $
-
-$9,523,600
-
Form type
-
4
-
Date filed
-
5/12/2025, 05:46 PM
Reporting Owners (1)
Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
Taira Thomas |
President, Special Projects |
300 E. RIO SALADO PKWY, TEMPE |
/s/ Paul Breaux, by Power of Attorney for Thomas Taira |
2025-05-12 |
0001607889 |
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CVNA |
Class A Common Stock |
Options Exercise |
$201K |
+20K |
+11.66% |
$10.07 |
192K |
May 8, 2025 |
Direct |
F1 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$6.88M |
-25K |
-13.05% |
$275.00 |
167K |
May 8, 2025 |
Direct |
F1 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$1.4M |
-5K |
-3% |
$280.00 |
162K |
May 8, 2025 |
Direct |
F1 |
transaction |
CVNA |
Class A Common Stock |
Sale |
-$1.45M |
-5K |
-3.1% |
$290.00 |
157K |
May 8, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CVNA |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-20K |
-9.94% |
$0.00 |
181K |
May 8, 2025 |
Class A Common Stock |
20K |
$10.07 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: